These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31173838)

  • 61. Neurocognitive performance in patients with depression compared to healthy controls: Association of clinical variables and remission state.
    Grützner TM; Sharma A; Listunova L; Bartolovic M; Weisbrod M; Roesch-Ely D
    Psychiatry Res; 2019 Jan; 271():343-350. PubMed ID: 30529317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder.
    Han H; Hou Y; Yao S; Hu S; Zhou Q; Yu X; McIntyre RS; Shi C
    Front Psychiatry; 2021; 12():763603. PubMed ID: 34887790
    [No Abstract]   [Full Text] [Related]  

  • 63. Cognitive dysfunction in Malaysian patients with major depressive disorder: A subgroup analysis of a multicountry, cross-sectional study.
    Zainal NZ; Kalita P; Herr KJ
    Asia Pac Psychiatry; 2019 Mar; 11(1):e12346. PubMed ID: 30511420
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Theory of mind impairment and its clinical correlates in patients with schizophrenia, major depressive disorder and bipolar disorder.
    Wang YY; Wang Y; Zou YM; Ni K; Tian X; Sun HW; Lui SSY; Cheung EFC; Suckling J; Chan RCK
    Schizophr Res; 2018 Jul; 197():349-356. PubMed ID: 29122405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. What is the overlap between subjective and objective cognitive impairments in MDD?
    Fava M; Mahableshwarkar AR; Jacobson W; Zhong W; Keefe RS; Olsen CK; Jaeger J
    Ann Clin Psychiatry; 2018 Aug; 30(3):176-184. PubMed ID: 30028891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.
    Yang Z; Abdul Rashid NA; Quek YF; Lam M; See YM; Maniam Y; Dauwels J; Tan BL; Lee J
    Schizophr Res; 2018 Sep; 199():58-63. PubMed ID: 29549976
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of cognitive deficits among drug-naive patients with schizophrenia and major depressive disorder.
    Hsu SE; Chen KC; Lee LT; Tsai HC; Lee IH; Chen PS; Yang YK
    J Affect Disord; 2015 Apr; 175():133-8. PubMed ID: 25616072
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormal coupling among spontaneous brain activity metrics and cognitive deficits in major depressive disorder.
    Zhu J; Zhang Y; Zhang B; Yang Y; Wang Y; Zhang C; Zhao W; Zhu DM; Yu Y
    J Affect Disord; 2019 Jun; 252():74-83. PubMed ID: 30981059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy.
    Moirand R; Galvao F; Lecompte M; Poulet E; Haesebaert F; Brunelin J
    Psychiatry Res; 2018 Jan; 259():476-481. PubMed ID: 29149717
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The lack of meaningful association between depression severity measures and neurocognitive performance.
    Keilp JG; Madden SP; Gorlyn M; Burke AK; Oquendo MA; Mann JJ
    J Affect Disord; 2018 Dec; 241():164-172. PubMed ID: 30121449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Examining the Link Between Cardiovascular Risk Factors and Neuropsychiatric Symptoms in Mild Cognitive Impairment and Major Depressive Disorder in Remission.
    Fischer CE; Kortebi I; Karameh WK; Kumar S; Gallagher D; Golas A; Munoz D; Barfett J; Butters MA; Bowie CR; Flint A; Rajji T; Herrmann N; Pollock BG; Mulsant B; Schweizer TA; Mah L;
    J Alzheimers Dis; 2019; 67(4):1305-1311. PubMed ID: 30741676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A cross-sectional study of functional disabilities and perceived cognitive dysfunction in patients with major depressive disorder in South Korea: The PERFORM-K study.
    Kim JM; Chalem Y; di Nicola S; Hong JP; Won SH; Milea D
    Psychiatry Res; 2016 May; 239():353-61. PubMed ID: 26908289
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment.
    Culpepper L
    J Clin Psychiatry; 2017; 78(9):e1432. PubMed ID: 29345880
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder.
    Shao TN; Yin GZ; Yin XL; Wu JQ; Du XD; Zhu HL; Liu JH; Wang XQ; Xu DW; Tang WJ; Hui L
    Compr Psychiatry; 2017 May; 75():103-109. PubMed ID: 28342378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N; Labad J; Urretavizcaya M; de Arriba-Arnau A; Segalàs C; Real E; Ferrer A; Crespo JM; Jiménez-Murcia S; Soriano-Mas C; Menchón JM; Soria V
    Psychoneuroendocrinology; 2017 Feb; 76():38-48. PubMed ID: 27883963
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.
    Van Rheenen TE; Lewandowski KE; Lipschitz JM; Burdick KE
    CNS Spectr; 2019 Feb; 24(1):16-21. PubMed ID: 30244687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictors of neurocognitive impairment at 2years after a first-episode major depressive disorder.
    Gu CZ; He HL; Duan HF; Su ZH; Chen H; Gan JL
    Compr Psychiatry; 2016 Jul; 68():24-33. PubMed ID: 27234179
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of cognitive impairment in general functioning in major depression.
    Baune BT; Miller R; McAfoose J; Johnson M; Quirk F; Mitchell D
    Psychiatry Res; 2010 Apr; 176(2-3):183-9. PubMed ID: 20138370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.